BIIB
Biogen Inc
Biotechnology
Biogen Inc (BIIB) Financials
Annual revenue, profit, EPS and free cash flow for BIIB, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $9.9B | — | — | — | $8.79 | $2.1B |
| FY2024 | $9.7B | — | — | — | $11.18 | $2.7B |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.